Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.
Massimino M, Barretta F, Dossena C, Minasi S, Buttarelli FR, Biassoni V, Oriani M, Schiavello E, Ficorilli M, Nigro O, Pollo B, Antonelli M, Donofrio V, Maggioni M, Kool M, Pecori E, Vennarini S, Giangaspero F, Gianno F, Erbetta A, Chiapparini L, Luksch R, Barzanò E, Meazza C, Podda M, Spreafico F, Terenziani M, Bergamaschi L, Ferrari A, Casanova M, Chiaravalli S, Gattuso G, Modena P, Bailey S, De Cecco L. Massimino M, et al. Among authors: nigro o. Neuro Oncol. 2025 Jan 12;27(1):209-218. doi: 10.1093/neuonc/noae189. Neuro Oncol. 2025. PMID: 39331528 Free PMC article.
Foreign patients and multicultural challenges in pediatric oncology: The experience of the Istituto Nazionale dei Tumori in Milan.
Lombardi M, Silva M, Giovanetti M, Cabibbe D, Luksch R, Terenziani M, Casanova M, Spreafico F, Meazza C, Podda M, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Bergamaschi L, Gattuso G, Nigro O, Sironi G, Colombo V, Ferrari A, Massimino M, Clerici CA. Lombardi M, et al. Among authors: nigro o. Pediatr Blood Cancer. 2024 Nov;71(11):e31260. doi: 10.1002/pbc.31260. Epub 2024 Aug 13. Pediatr Blood Cancer. 2024. PMID: 39138601
Caring for children with cancer evacuated from Ukraine: The patients' perception.
Bolognese M, Massimino M, Cabibbe D, Zecca M, Fornara M, Armiraglio M, Kyzima R, Luksch R, Terenziani M, Casanova M, Spreafico F, Meazza C, Podda M, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Hovsepyan S, Bergamaschi L, Gattuso G, Nigro O, Grampa P, Adduci A, Ferrari A, Clerici CA. Bolognese M, et al. Among authors: nigro o. Pediatr Blood Cancer. 2024 Aug;71(8):e31087. doi: 10.1002/pbc.31087. Epub 2024 May 20. Pediatr Blood Cancer. 2024. PMID: 38769590
Life strategies for Aminicenantia in subseafloor oceanic crust.
Booker AE, D'Angelo T, Adams-Beyea A, Brown JM, Nigro O, Rappé MS, Stepanauskas R, Orcutt BN. Booker AE, et al. Among authors: nigro o. ISME J. 2023 Sep;17(9):1406-1415. doi: 10.1038/s41396-023-01454-5. Epub 2023 Jun 16. ISME J. 2023. PMID: 37328571 Free PMC article.
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M, Vennarini S, Buttarelli FR, Antonelli M, Colombo F, Minasi S, Pecori E, Ferroli P, Giussani C, Schiariti M, Schiavello E, Biassoni V, Erbetta A, Chiapparini L, Nigro O, Boschetti L, Gianno F, Miele E, Modena P, De Cecco L, Pollo B, Barretta F. Massimino M, et al. Among authors: nigro o. J Neurooncol. 2023 Jul;163(3):577-586. doi: 10.1007/s11060-023-04361-z. Epub 2023 Jun 16. J Neurooncol. 2023. PMID: 37326761
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance.
Nigro O, Podda MG, Pellegatta F, Schiavello E, Clerici CA, Catalano I, Visconti G, Albarini M, Luksch R, Terenziani M, Ferrari A, Casanova M, Biassoni V, Meazza C, Spreafico F, Gattuso G, Sironi G, Puma N, Bergamaschi L, Chiaravalli S, Massimino M. Nigro O, et al. Tumori. 2023 Dec;109(6):NP6-NP10. doi: 10.1177/03008916231168670. Epub 2023 May 8. Tumori. 2023. PMID: 37154050
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Cortellini A, D'Alessio A, Cleary S, Buti S, Bersanelli M, Bordi P, Tonini G, Vincenzi B, Tucci M, Russo A, Pantano F, Russano M, Stucci LS, Sergi MC, Falconi M, Zarzana MA, Santini D, Spagnolo F, Tanda ET, Rastelli F, Giorgi FC, Pergolesi F, Giusti R, Filetti M, Lo Bianco F, Marchetti P, Botticelli A, Gelibter A, Siringo M, Ferrari M, Marconcini R, Vitale MG, Nicolardi L, Chiari R, Ghidini M, Nigro O, Grossi F, De Tursi M, Di Marino P, Queirolo P, Bracarda S, Macrini S, Inno A, Zoratto F, Veltri E, Spoto C, Vitale MG, Cannita K, Gennari A, Morganstein DL, Mallardo D, Nibid L, Sabarese G, Brunetti L, Perrone G, Ascierto PA, Ficorella C, Pinato DJ. Cortellini A, et al. Among authors: nigro o. Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. doi: 10.1158/1078-0432.CCR-22-3116. Clin Cancer Res. 2023. PMID: 37125965
92 results